Das Klinikum

Frau Dr. med. Melis Gür

Frau Dr. med. Melis Gür

Fachärztin für Urologie

Kontakt

Telefonnummer: 07071 29-

E-Mail-Adresse: melis.guer@med.uni-tuebingen.de

Klinik / Institut / Zentrum

  • Mikroultraschall-Diagnostik für Prostatakrebs
  • Uro-Onkologie
  • Auslandsstipendium, Clinical Fellowship, Division of Urology, University Hospital Alberta, Edmonton, Alberta/Kanada 2026-2027
  • Auslandsstipendium, Research Fellowship, Division of Urology, University of California San Diego, USA 2024
  • 2025
    Fellow of the European Board of Urology (FEBU)
  • Guer M, Brisbane WG, Cash H, Ghai S, Klotz L, Wilson PFR, Kinnaird A. Micro-ultrasound for prostate cancer. Nat Rev Urol. 2025 Nov 27. doi: 10.1038/s41585-025-01111-w. Epub ahead of print. PMID: 41310306.
  • Characterization of FOLH1 Expression in Renal Cell Carcinoma.Ovruchesky E, Pan E, Guer M, Elliott A, Siva S, Ravi P, McGregor B, Bagrodia A, Derweesh I, Barata P, Heath EI, Antonarakis ES, Darabi S, Hoon DSB, Mortazavi A, Choueiri TK, Nabhan C, Wei S, McKay RR.Cancers (Basel). 2024 May 13;16(10):1855. doi: 10.3390/cancers16101855.
  • Chen YW, Guer M, McKay RR. Long-term HIF-2α inhibition in von Hippel-Lindau disease: insights from LITESPARK-004. Transl Androl Urol. 2025 Oct 31;14(10):2781-2785. doi: 10.21037/tau-2025-565. Epub 2025 Oct 24. PMID: 41230136; PMCID: PMC12603843.
  • Guer M, Janitzky A, Schostak M. On-treatment risk model for predicting treatment response in advanced renal cell carcinoma. World J Urol. 2023 Oct;41(10):2735-2742. doi: 10.1007/s00345-023-04545-2. Epub 2023 Aug 8. PMID: 37552264; PMCID: PMC10582135.
  • Guer M, Jani C, Hanbury G, Arora S, Jani R, Ly K, Schostak M, Bagrodia A, Rose B, Derweesh IH, McKay RR. Examining the evolving landscape of kidney cancer mortality in the United States. Oncologist. 2025 Apr 4;30(4):oyae373. doi: 10.1093/oncolo/oyae373. PMID: 40304256; PMCID: PMC12041913.
  • Argow MJ, Hupfeld S, Schenke SA, Neumann S, Damm R, Vogt J, Guer M, Wuestemann J, Schostak M, Fischbach F, Kreissl MC. Comparison of mpMRI and 68Ga-PSMA-PET/CT in the Assessment of the Primary Tumors in Predominant Low-/Intermediate-Risk Prostate Cancer. Diagnostics (Basel). 2025 May 28;15(11):1358. doi: 10.3390/diagnostics15111358. PMID: 40506931; PMCID: PMC12155535.
  • Dabbas MR, Guer M, Musso G, Garofano G, Meagher MF, Puri D, Yuen KL, Capitanio U, Larcher A, Saitta C, Kim B, Karamcheti S, Baker BH, Saito K, Yasuda Y, Patil D, Briganti A, Salonia A, Fujii Y, Master V, Montorsi F, Derweesh IH. Predictors of Survival and Recurrence After Partial or Radical Nephrectomy in Women with Localized Renal Cell Carcinoma: A Multicenter Analysis. Clin Genitourin Cancer. 2026 Feb;24(1):102460. doi: 10.1016/j.clgc.2025.102460. Epub 2025 Oct 23. PMID: 41285665.